Tsoukas C D, Fox R I, Slovin S F, Carson D A, Pellegrino M, Fong S, Pasquali J L, Ferrone S, Kung P, Vaughan J H
J Immunol. 1981 May;126(5):1742-6.
We have stimulated human peripheral blood lymphocytes in vitro with autologous EBV-infected or noninfected B cells. A cytotoxic response was obtained only when virally infected cells were used. The activity of the effector cells was restricted by the major histocompatibility complex and was directed against EBV-genome-bearing targets. The highest cytolytic response was obtained when lymphocytes of individuals previously exposed to the virus (EBV-VCA positive) were used. Lymphocytes of noninfected donors (EBV-VCA negative) gave a low response; the relative frequency of their effector cells was at least 4-fold lower. Lymphocytes of newborns did not respond. The cytotoxic activity was mediated by T lymphocytes of the cytotoxic/suppressor subset, as determined by cytofluorographic analysis and antibody plus complement-mediated lysis, using monoclonal antibodies to human lymphocyte surface antigen.
我们在体外用人自身感染EBV或未感染EBV的B细胞刺激人外周血淋巴细胞。仅当使用病毒感染的细胞时才获得细胞毒性反应。效应细胞的活性受主要组织相容性复合体限制,并针对携带EBV基因组的靶标。当使用先前接触过该病毒的个体(EBV-VCA阳性)的淋巴细胞时,获得最高的溶细胞反应。未感染供体(EBV-VCA阴性)的淋巴细胞反应较低;其效应细胞的相对频率至少低4倍。新生儿的淋巴细胞无反应。细胞毒性活性由细胞毒性/抑制性子集的T淋巴细胞介导,这是通过细胞荧光分析以及使用针对人淋巴细胞表面抗原的单克隆抗体进行抗体加补体介导的裂解来确定的。